The adenosine subtype 1 (A(1)) receptor, which may influence cardiac functi
on and modulate renal function, may have particular relevance in congestive
heart failure (CHF). However, the effects of A, receptor inhibition in the
setting of CHF are poorly defined. Systemic hemodynamics and indices of re
nal function were measured in pigs with pacing-induced CHF at 240 bpm for 3
weeks (n = 10) before and after A(1) receptor blockade with 100 mug of BG9
719 (1,3-dipropyl-8-[2-(5,6-epoxynorbornyl)]xanthene) or in CHF pigs after
infusion of vehicle only (n = 10). Heart rate, mean aortic pressure, and le
ft ventricular peak pressure increased following A(1) blockade in the CHF g
roup, consistent with an adenosine inhibitory effect. However, cardiac outp
ut and global measures of vascular resistance did not significantly change
following A(1) blockade. Urine output increased twofold and sodium clearanc
e increased threefold following A(1) blockade (p < 0.05). Creatinine cleara
nce increased following A(1) blockade (127 +/- 17 vs. 62 +/- 7 ml/min, p <
0.05). Selective A(1) receptor blockade improved glomerular filtration rate
and induced a natriuresis and diuresis in a model of CHF without adverse e
ffects on cardiac function. These unique results suggest that renal A(1) re
ceptor activation may contribute to the reduced renal function associated w
ith CHF.